pharma

China’s new commercial insurance formulary looks to expand patient access to Alzheimer’s disease medicines from Eli Lilly and…

UK lowers new medicine rebate scheme to 14.5% for 2026 Endpoints NewsWhat will be the cost of Keir Starmer’s…

Updated: CMS unveils negotiated prices for Ozempic, Wegovy and other drugs from second round of IRA talks Endpoints NewsU.S.…

The new NICE threshold will be £25,000 to £35,000 per quality adjusted life year gained over and above…

The WHO wants pharma companies to consider tiered pricing (lower prices in lower-income countries) and voluntary licensing of…

The boundaries between pharmaceuticals and nutraceuticals continue to blur. This year’s CPHI 2025 trade show highlighted innovations that…

The U.K. is locked in drug-pricing negotiations with the Trump administration and pharmaceutical firms about how much the…

Wednesday 05 November 2025 8:35 pm Share Facebook Share on Facebook X Share on Twitter LinkedIn Share on…

But for the U.S. pharmaceutical company — which shelved its planned facility meant to support early-stage life sciences…

Ministers agreed last week to a two-week extension to the deadline by which pharma firms must tell the…

BOSTON — The president of a leading addiction medicine group issued stark warnings on hardline Trump administration policies…

A U.K. government spokesperson said: “The pharmaceutical sector and the innovative medicines it produces are critical to our…

China’s new commercial insurance model could broaden access to Alzheimer’s drugs